Posts Tagged ‘Medtech’
Life Sciences spotlight: GenomeKey
Next-generation life sciences company, GenomeKey, was recently awarded $11.4m to transform sepsis diagnosis and treatment. We had a chat with CEO, Dr Michael Roberts, to hear his story… GenomeKey at a glance: Market sector: Life Sciences Location: Bristol Number of employees: 25 Amount of funding raised: Over £16m Company growth status: Commercialisation Let’s start with GenomeKey’s…
Read MoreMedtech startup Neuronostics raises over £2 million
Multi-award-winning medtech startup, Neuronostics, has raised more than £2m in funding to develop its pioneering epilepsy diagnosis technology. The company received £2.1m in an oversubscribed seed funding round led by the Ascension Life Fund. Chris Wheatcroft, Investment Director at the Ascension Life Fund said: “We are delighted to have invested in Neuronostics, whose software as…
Read MoreMilbotix announce investment round and grant funding for SmartSocks™
University of Bristol spinout Milbotix has announced an investment round to complete the development of its SmartSocks™ product line, which aims to help millions of people living with dementia, non-verbal autism and other conditions that affect communication. SmartSocks™ is being developed in collaboration with the UK Dementia Research Institute and University of Exeter Medical School.…
Read MoreHealthtech products – from innovation to implementation
There is a vibrant healthtech* cluster in the South West region, with over 90 healthtech startups alone in Bristol. This sector has huge potential for Bristol, but it also has significant market challenges, from how to navigate the NHS to the rapidly evolving international digital regulatory landscape. In this article we share advice for healthtech…
Read MoreRadii Devices: Redefining prosthetics and orthotics
Following our member Radii Devices‘ recent grant funding success with Innovate UK’s Biomedical Catalyst fund, we had a chat with Founder and CEO, Joshua Steer, to find out about his journey from researcher to medtech startup… Radii Devices key facts Start date: April 2020 Market sector: Medtech Location: Engine Shed, Bristol Number of employees: 6 Company growth status: About…
Read MoreBiomaterials startup Zentraxa announce seed investment
Our member company and University of Bristol spin-out, Zentraxa, has raised capital investment from Future Planet Capital, BPEC and Science Angel Syndicate to develop their innovative Zentide platform for engineering bespoke biomaterials. With generous support of their recently awarded Innovate UK grant, Zentraxa is rapidly moving towards contracted commercial concept development in both medical adhesives…
Read MoreFluoretiQ announces the closure of £1.1 million funding round
Our member and University of Bristol spin-out, FluoretiQ, has today announced the completion of a £1.1 million, pre-series A investment. Their pioneering NANOPLEX technology is a 15-minute proprietary diagnostic platform for bacterial infections. The round was led by early-stage life science investors, Deepbridge Capital LLP, with significant participation from MAINStream, OION, SAIC and existing investors. This…
Read MoreFluoretiQ case study: Revolutionising bacterial diagnostics
To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with FluoretiQ Co-founder and CEO, Neciah Dorh… FluoretiQ Key Facts Start date: 2 March 2017 Market sector: Healthcare (Diagnostics) Location: Bristol Number of employees: 10…
Read MoreAirway Medical complete first working prototype
Our member, Airway Medical, in collaboration with the University of Portsmouth and Versarien PLC have announced the conclusion of their project to further the development of The AMSU™ – a novel airway suction device that will soon be helping to save the lives of patients with blocked airways and improving the well-being of people with…
Read MoreGenomeKey case study: Saving lives through early diagnosis of sepsis
To help our aspiring entrepreneurs and future SETsquared Bristol members, we showcase member and alumni case studies demonstrating the breadth of tech at SETsquared Bristol and what it takes to achieve success. We had a chat with GenomeKey CEO, Michael Roberts… GenomeKey Facts Start date: August 2019 Market sector: Medtech/diagnostics Location: Bristol Number of employees: 9 growing to 12 and beyond Amount…
Read More